Drug Shortage Report for ALPROLIX
| Report ID | 196825 |
| Drug Identification Number | 02422956 |
| Brand name | ALPROLIX |
| Common or Proper name | Coagulation Factor IX (Recombinant), Fc Fusion Protein |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN |
| Strength(s) | 3000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION KIT |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3000 IU/vial |
| ATC code | B02BD |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-28 |
| Estimated end date | 2023-07-10 |
| Actual end date | 2023-07-07 |
| Shortage status | Resolved |
| Updated date | 2023-07-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-07-10 | French | Compare |
| v3 | 2023-07-10 | English | Compare |
| v2 | 2023-06-29 | French | Compare |
| v1 | 2023-06-29 | English | Compare |
Showing 1 to 4 of 4